LABStandard BioTools Inc.

$370M

Q1 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$26M-12.0% YoY

Gross Profit

$14M53.1% margin

Operating Income

-$18M-68.7% margin

Net Income

-$17M-67.4% margin

EPS (Diluted)

$-0.59

QoQ Revenue Growth

+1.8%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$9M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$292M

Total Liabilities

$254M

Stockholders' Equity

$39M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$26M	$29M	-12.0%
Gross Profit	$14M	$17M	-20.3%
Operating Income	-$18M	-$19M	+7.1%
Net Income	-$17M	-$20M	+13.5%

Geographic Segments

UNITED STATES

$12M46%

Europe

$8M30%

Asia Pacific

$5M20%

Other Geographical Countries

$1M4%

LAB Q1 2017 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena